Despite the drastic reduction in plasma glucagon by pharmacological antagonism of the V1bR or genetic KO of Avpr1b, the depth of hypoglycemia was not affected (Figure 4a and c). The gene discussed is AVPR1B; the disease is Hypoglycemia.